Dice CEO: Energy, T...
Health Care: Health Services
Antares Pharma Inc. (AIS: AMEX)
$2.76 0.04 | 1.47%
06/01/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 16.46M | 12.82M | 8.31M | 5.66M |
| Cost of Sales | 6.63M | 4.08M | 3.71M | 1.47M |
| Gross Operating Profit | 9.83M | 8.73M | 4.60M | 4.19M |
| Selling, General, and Administrative Expenses | 7.40M | 5.77M | 5.96M | 7.97M |
| Research & Development | 6.70M | 8.80M | 7.90M | 7.87M |
| Operating Income before D & A (EBITDA) | -4.27M | -5.84M | -9.26M | -11.65M |
| Depreciation & Amortization | 168.17K | 188.75K | 432.90K | 552.87K |
| Interest Income | 55.59K | 30.68K | 27.27K | 553.06K |
| Other Income - Net | -5.84K | -90.95K | 9.08K | -23.87K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -4.39M | -6.09M | -9.66M | -11.67M |
| Interest Expense | 887.00 | 4.46K | 633.46K | 1.02M |
| Pre-Tax Income | -4.39M | -6.09M | -10.29M | -12.69M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -4.39M | -6.09M | -10.29M | -12.69M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -4.39M | -6.09M | -10.29M | -12.69M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -4.39M | -6.09M | -10.29M | -12.69M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-4.39M | -6.09M | -10.29M | -12.69M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -4.39M | -6.09M | -10.29M | -12.69M |
| Basic EPS from Continuing Ops. | -0.05 | -0.07 | -0.14 | -0.19 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.05 | -0.07 | -0.14 | -0.19 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.05 | -0.07 | -0.14 | -0.19 |
| Basic Normalized Net Income/Share | -0.05 | -0.07 | -0.14 | -0.19 |
| EPS fr Continuing Ops. | -0.05 | -0.07 | -0.14 | -0.19 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.05 | -0.07 | -0.14 | -0.19 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.05 | -0.07 | -0.14 | -0.19 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.05 | -0.07 | -0.14 | -0.19 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with AIS
- Portfolio NameUser Type
- Contributor5 Stocks Under-$10 Setting ...
- UserSMITTY
- Contributor8 Health Care Stocks With R...
- ContributorBreakout Stocks Of The Week...
- UserCurrent
- Userparvardigar
- Userhpats Portfolio 1
- Contributor11 Penny Stocks to Sell Now
- Userphospho
- UserTraderO4000 Portfolio 1
Latest AIS Headlines from TheStreet
- Antares Stock Hits New 52-Week High (AIS) 03.20.12 | 11:03 am
- Antares Pharma Inc. Stock Upgraded (AIS) 03.14.12 | 05:03 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Antares Stock Gaps Down On Today's Open (AIS) 12.15.11 | 09:12 am
- BioSante Pharma Readying Release of 'Female Viagra' Study Results 12.14.11 | 12:12 pm
- 5 Stocks Under $10 With Big Upside Potential 11.18.11 | 06:11 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- 4 Stocks Setting Up to Break Out 06.10.11 | 03:06 pm
- 11 Penny Stocks to Sell Now 07.20.10 | 11:07 am
- Hot Penny Stocks to Buy 06.14.10 | 11:06 am
Press Releases for AIS
- Antares Pharma To Present At The Jefferies Global Healthcare Conference - Business Wire 05.31.12 | 07:05 am
- Antares Pharma Reports First Quarter 2012 Financial And Operating Results - Business Wire 05.08.12 | 07:05 am
- Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva And Pfizer - Business Wire 04.26.12 | 09:04 am
- Antares Pharma To Present At The 11th Annual Needham Healthcare Conference - Business Wire 03.28.12 | 07:03 am
- Antares Pharma Reports Fourth Quarter And Full Year 2011 Financial And Operating Results - Business Wire 03.12.12 | 07:03 am
- Antares Pharma To Host Fourth Quarter And Full Year 2011 Earnings Call - Business Wire 03.05.12 | 07:03 am
- Antares Pharma To Present At Upcoming Investor Conferences - Business Wire 02.29.12 | 07:02 am
- Antares Pharma Appoints John J. Howarth Vice President Of Corporate Affairs - Business Wire 02.27.12 | 09:02 am
- Antares Pharma Enters Licensing Agreement With Daewoong Pharmaceuticals Co. Ltd. For Oxybutynin Gel 3% In South Korea - Business Wire 01.17.12 | 08:01 am
- Antares Pharma Enters Licensing Agreement With Pfizer Consumer Healthcare - Business Wire 12.20.11 | 09:12 am
Partner Headlines for AIS
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 05.14.12 | 09:05 am
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- A Bio-Pharma Watch List For This Week: 4 Buys, 1 Sell - Seeking Alpha 02.22.12 | 09:02 am
- SIGA Could Be Ready For A Large Short-Term Pop - Seeking Alpha 01.15.12 | 09:01 am
- Antares Pharma's New Blockbuster Drug Has Potential To Generate Long-Term Revenue - Seeking Alpha 12.28.11 | 06:12 am
- Watson-Amgen to Develop Biosimilars - Analyst Blog - Zacks 12.20.11 | 10:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
